 | • レポートコード：D0GIR-06836 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、静脈内（IV）溶液の世界市場を広く調査・分析し、今後の市場展望をまとめております。静脈内（IV）溶液の種類別市場規模（完全非経口溶液、末梢非経口溶液）、用途別市場規模（病院・診療所、外来、在宅医療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：ICU Medical、Baxter、B. Braun Melsungen、Grifols、Fresenius Kabi、Terumo Medical Corporation、Amanta Healthcare ・地域別グローバル市場分析 2015年-2020年 ・静脈内（IV）溶液の北米市場（アメリカ、カナダ、メキシコ） ・静脈内（IV）溶液のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・静脈内（IV）溶液のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・静脈内（IV）溶液の南米市場（ブラジル、アルゼンチン） ・静脈内（IV）溶液の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：完全非経口溶液、末梢非経口溶液 ・用途別分析：病院・診療所、外来、在宅医療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Intravenous (IV) Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 9330.3 million by 2025, from USD 7922.8 million in 2019.
The Intravenous (IV) Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Intravenous (IV) Solution market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Intravenous (IV) Solution market has been segmented into
Total Parenteral Solution
Peripheral Parenteral Solution
By Application, Intravenous (IV) Solution has been segmented into:
Hospitals & Clinics
Ambulatory
Homecare
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Intravenous (IV) Solution market presented in the report. This section sheds light on the sales growth of different regional and country-level Intravenous (IV) Solution markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Intravenous (IV) Solution market.
The report offers in-depth assessment of the growth and other aspects of the Intravenous (IV) Solution market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Intravenous (IV) Solution Market Share Analysis
Intravenous (IV) Solution competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Intravenous (IV) Solution sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Intravenous (IV) Solution sales, revenue and market share for each player covered in this report.
The major players covered in Intravenous (IV) Solution are:
ICU Medical
Baxter
B. Braun Melsungen
Grifols
Fresenius Kabi
Terumo Medical Corporation
Amanta Healthcare
Among other players domestic and global, Intravenous (IV) Solution market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous (IV) Solution product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous (IV) Solution, with price, sales, revenue and global market share of Intravenous (IV) Solution in 2018 and 2019.
Chapter 3, the Intravenous (IV) Solution competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous (IV) Solution breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Intravenous (IV) Solution market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Intravenous (IV) Solution sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Intravenous (IV) Solution Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous (IV) Solution Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Total Parenteral Solution
1.2.3 Peripheral Parenteral Solution
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous (IV) Solution Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory
1.3.4 Homecare
1.4 Overview of Global Intravenous (IV) Solution Market
1.4.1 Global Intravenous (IV) Solution Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ICU Medical
2.1.1 ICU Medical Details
2.1.2 ICU Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 ICU Medical SWOT Analysis
2.1.4 ICU Medical Product and Services
2.1.5 ICU Medical Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Baxter SWOT Analysis
2.2.4 Baxter Product and Services
2.2.5 Baxter Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 B. Braun Melsungen
2.3.1 B. Braun Melsungen Details
2.3.2 B. Braun Melsungen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 B. Braun Melsungen SWOT Analysis
2.3.4 B. Braun Melsungen Product and Services
2.3.5 B. Braun Melsungen Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Grifols SWOT Analysis
2.4.4 Grifols Product and Services
2.4.5 Grifols Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Fresenius Kabi SWOT Analysis
2.5.4 Fresenius Kabi Product and Services
2.5.5 Fresenius Kabi Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Terumo Medical Corporation
2.6.1 Terumo Medical Corporation Details
2.6.2 Terumo Medical Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Terumo Medical Corporation SWOT Analysis
2.6.4 Terumo Medical Corporation Product and Services
2.6.5 Terumo Medical Corporation Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amanta Healthcare
2.7.1 Amanta Healthcare Details
2.7.2 Amanta Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amanta Healthcare SWOT Analysis
2.7.4 Amanta Healthcare Product and Services
2.7.5 Amanta Healthcare Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Intravenous (IV) Solution Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Intravenous (IV) Solution Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Intravenous (IV) Solution Manufacturer Market Share in 2019
3.3.2 Top 6 Intravenous (IV) Solution Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Intravenous (IV) Solution Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous (IV) Solution Sales and Market Share by Regions (2015-2020)
4.1.2 Global Intravenous (IV) Solution Revenue and Market Share by Regions (2015-2020)
4.2 North America Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
4.3 Europe Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
4.5 South America Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Intravenous (IV) Solution Sales, Revenue and Market Share by Country
5.1.1 North America Intravenous (IV) Solution Sales and Market Share by Country (2015-2020)
5.1.2 North America Intravenous (IV) Solution Revenue and Market Share by Country (2015-2020)
5.2 United States Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
5.3 Canada Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
5.4 Mexico Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Intravenous (IV) Solution Sales, Revenue and Market Share by Country
6.1.1 Europe Intravenous (IV) Solution Sales and Market Share by Country (2015-2020)
6.1.2 Europe Intravenous (IV) Solution Revenue and Market Share by Country (2015-2020)
6.2 Germany Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
6.3 UK Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
6.4 France Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
6.5 Russia Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
6.6 Italy Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Intravenous (IV) Solution Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Intravenous (IV) Solution Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Intravenous (IV) Solution Revenue and Market Share by Regions (2015-2020)
7.2 China Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
7.3 Japan Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
7.4 Korea Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
7.5 India Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
7.7 Australia Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Intravenous (IV) Solution Sales, Revenue and Market Share by Country
8.1.1 South America Intravenous (IV) Solution Sales and Market Share by Country (2015-2020)
8.1.2 South America Intravenous (IV) Solution Revenue and Market Share by Country (2015-2020)
8.2 Brazil Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
8.3 Argentina Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Intravenous (IV) Solution Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Intravenous (IV) Solution Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Intravenous (IV) Solution Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
9.3 Turkey Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
9.4 Egypt Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
9.5 South Africa Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Intravenous (IV) Solution Sales and Market Share by Type (2015-2020)
10.2 Global Intravenous (IV) Solution Revenue and Market Share by Type (2015-2020)
10.3 Global Intravenous (IV) Solution Price by Type (2015-2020)
11 Global Intravenous (IV) Solution Market Segment by Application
11.1 Global Intravenous (IV) Solution Sales Market Share by Application (2015-2020)
11.2 Global Intravenous (IV) Solution Revenue Market Share by Application (2015-2020)
11.3 Global Intravenous (IV) Solution Price by Application (2015-2020)
12 Market Forecast
12.1 Global Intravenous (IV) Solution Sales, Revenue and Growth Rate (2021-2025)
12.2 Intravenous (IV) Solution Market Forecast by Regions (2021-2025)
12.2.1 North America Intravenous (IV) Solution Market Forecast (2021-2025)
12.2.2 Europe Intravenous (IV) Solution Market Forecast (2021-2025)
12.2.3 Asia-Pacific Intravenous (IV) Solution Market Forecast (2021-2025)
12.2.4 South America Intravenous (IV) Solution Market Forecast (2021-2025)
12.2.5 Middle East & Africa Intravenous (IV) Solution Market Forecast (2021-2025)
12.3 Intravenous (IV) Solution Market Forecast by Type (2021-2025)
12.3.1 Global Intravenous (IV) Solution Sales Forecast by Type (2021-2025)
12.3.2 Global Intravenous (IV) Solution Market Share Forecast by Type (2021-2025)
12.4 Intravenous (IV) Solution Market Forecast by Application (2021-2025)
12.4.1 Global Intravenous (IV) Solution Sales Forecast by Application (2021-2025)
12.4.2 Global Intravenous (IV) Solution Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Intravenous (IV) Solution Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Intravenous (IV) Solution by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Intravenous (IV) Solution Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. ICU Medical Basic Information, Manufacturing Base and Competitors
Table 8. ICU Medical Intravenous (IV) Solution Major Business
Table 9. ICU Medical Intravenous (IV) Solution Total Revenue (USD Million) (2018-2019)
Table 10. ICU Medical SWOT Analysis
Table 11. ICU Medical Intravenous (IV) Solution Product and Services
Table 12. ICU Medical Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Baxter Basic Information, Manufacturing Base and Competitors
Table 14. Baxter Intravenous (IV) Solution Major Business
Table 15. Baxter Intravenous (IV) Solution Total Revenue (USD Million) (2018-2019)
Table 16. Baxter SWOT Analysis
Table 17. Baxter Intravenous (IV) Solution Product and Services
Table 18. Baxter Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. B. Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 20. B. Braun Melsungen Intravenous (IV) Solution Major Business
Table 21. B. Braun Melsungen Intravenous (IV) Solution Total Revenue (USD Million) (2018-2019)
Table 22. B. Braun Melsungen SWOT Analysis
Table 23. B. Braun Melsungen Intravenous (IV) Solution Product and Services
Table 24. B. Braun Melsungen Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Grifols Basic Information, Manufacturing Base and Competitors
Table 26. Grifols Intravenous (IV) Solution Major Business
Table 27. Grifols Intravenous (IV) Solution Total Revenue (USD Million) (2018-2019)
Table 28. Grifols SWOT Analysis
Table 29. Grifols Intravenous (IV) Solution Product and Services
Table 30. Grifols Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 32. Fresenius Kabi Intravenous (IV) Solution Major Business
Table 33. Fresenius Kabi Intravenous (IV) Solution Total Revenue (USD Million) (2018-2019)
Table 34. Fresenius Kabi SWOT Analysis
Table 35. Fresenius Kabi Intravenous (IV) Solution Product and Services
Table 36. Fresenius Kabi Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Terumo Medical Corporation Basic Information, Manufacturing Base and Competitors
Table 38. Terumo Medical Corporation Intravenous (IV) Solution Major Business
Table 39. Terumo Medical Corporation Intravenous (IV) Solution Total Revenue (USD Million) (2018-2019)
Table 40. Terumo Medical Corporation SWOT Analysis
Table 41. Terumo Medical Corporation Intravenous (IV) Solution Product and Services
Table 42. Terumo Medical Corporation Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Amanta Healthcare Basic Information, Manufacturing Base and Competitors
Table 44. Amanta Healthcare Intravenous (IV) Solution Major Business
Table 45. Amanta Healthcare Intravenous (IV) Solution Total Revenue (USD Million) (2018-2019)
Table 46. Amanta Healthcare SWOT Analysis
Table 47. Amanta Healthcare Intravenous (IV) Solution Product and Services
Table 48. Amanta Healthcare Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Intravenous (IV) Solution Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Intravenous (IV) Solution Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Intravenous (IV) Solution Sales by Regions (2015-2020) (K Units)
Table 52. Global Intravenous (IV) Solution Sales Market Share by Regions (2015-2020)
Table 53. Global Intravenous (IV) Solution Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Intravenous (IV) Solution Sales by Countries (2015-2020) (K Units)
Table 55. North America Intravenous (IV) Solution Sales Market Share by Countries (2015-2020)
Table 56. North America Intravenous (IV) Solution Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Intravenous (IV) Solution Revenue Market Share by Countries (2015-2020)
Table 58. Europe Intravenous (IV) Solution Sales by Countries (2015-2020) (K Units)
Table 59. Europe Intravenous (IV) Solution Sales Market Share by Countries (2015-2020)
Table 60. Europe Intravenous (IV) Solution Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Intravenous (IV) Solution Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Intravenous (IV) Solution Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Intravenous (IV) Solution Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Intravenous (IV) Solution Sales by Countries (2015-2020) (K Units)
Table 65. South America Intravenous (IV) Solution Sales Market Share by Countries (2015-2020)
Table 66. South America Intravenous (IV) Solution Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Intravenous (IV) Solution Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Intravenous (IV) Solution Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Intravenous (IV) Solution Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Intravenous (IV) Solution Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Intravenous (IV) Solution Revenue Market Share by Countries (2015-2020)
Table 72. Global Intravenous (IV) Solution Sales by Type (2015-2020) (K Units)
Table 73. Global Intravenous (IV) Solution Sales Share by Type (2015-2020)
Table 74. Global Intravenous (IV) Solution Revenue by Type (2015-2020) (USD Million)
Table 75. Global Intravenous (IV) Solution Revenue Share by Type (2015-2020)
Table 76. Global Intravenous (IV) Solution Sales by Application (2015-2020) (K Units)
Table 77. Global Intravenous (IV) Solution Sales Share by Application (2015-2020)
Table 78. Global Intravenous (IV) Solution Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Intravenous (IV) Solution Market Share Forecast by Regions (2021-2025)
Table 80. Global Intravenous (IV) Solution Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Intravenous (IV) Solution Market Share Forecast by Type (2021-2025)
Table 82. Global Intravenous (IV) Solution Sales Forecast by Application (2021-2025)
Table 83. Global Intravenous (IV) Solution Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Intravenous (IV) Solution Picture
Figure 2. Global Sales Market Share of Intravenous (IV) Solution by Type in 2019
Figure 3. Total Parenteral Solution Picture
Figure 4. Peripheral Parenteral Solution Picture
Figure 5. Intravenous (IV) Solution Sales Market Share by Application in 2018
Figure 6. Hospitals & Clinics Picture
Figure 7. Ambulatory Picture
Figure 8. Homecare Picture
Figure 9. Global Intravenous (IV) Solution Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Intravenous (IV) Solution Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Intravenous (IV) Solution Sales Market Share by Manufacturer in 2019
Figure 30. Global Intravenous (IV) Solution Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Intravenous (IV) Solution Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Intravenous (IV) Solution Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Intravenous (IV) Solution Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Intravenous (IV) Solution Revenue Market Share by Regions (2015-2020)
Figure 37. Global Intravenous (IV) Solution Revenue Market Share by Regions in 2018
Figure 38. North America Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
Figure 39. Europe Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
Figure 41. South America Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Intravenous (IV) Solution Sales and Growth Rate (2015-2020)
Figure 43. North America Intravenous (IV) Solution Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Intravenous (IV) Solution Sales Market Share by Countries (2015-2020)
Figure 45. North America Intravenous (IV) Solution Sales Market Share by Countries in 2018
Figure 46. North America Intravenous (IV) Solution Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Intravenous (IV) Solution Revenue Market Share by Countries in 2018
Figure 48. United States Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Intravenous (IV) Solution Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Intravenous (IV) Solution Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Intravenous (IV) Solution Revenue Market Share by Countries in 2019
Figure 54. Germany Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Intravenous (IV) Solution Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Intravenous (IV) Solution Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Intravenous (IV) Solution Revenue Market Share by Regions 2019
Figure 62. China Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Intravenous (IV) Solution Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Intravenous (IV) Solution Sales Market Share by Countries in 2019
Figure 69. South America Intravenous (IV) Solution Revenue Market Share by Countries in 2019
Figure 70. Brazil Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Intravenous (IV) Solution Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Intravenous (IV) Solution Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Intravenous (IV) Solution Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Intravenous (IV) Solution Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Intravenous (IV) Solution Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Intravenous (IV) Solution Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Intravenous (IV) Solution Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Intravenous (IV) Solution Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Intravenous (IV) Solution Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Intravenous (IV) Solution Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Intravenous (IV) Solution Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
創傷灌漑ソリューションの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Wound Irrigation Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wound Irrigation So…- ミノキシジル溶液の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Minoxidil Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- ユーザー認証ソリューションの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global User Authentication Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The User Authenticat…
- 海水淡水化ソリューションの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Seawater Desalination Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 骨盤健康ソリューションの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Pelvic Health Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…